Among the T cells, both the CD4+ and CD8+ subpopulations were ~10-fold larger, while the percentage of CD4+Foxp3+ T regulatory (Treg) cells, which are negative regulators of antitumour immunity, was much smaller in tumours from TIOs+NIR3-treated mice (Fig. 6l). The gene discussed is CD4; the disease is neoplasm.